Vimarsana.com

Latest Breaking News On - Painreform ltd - Page 8 : vimarsana.com

PainReform Gains 5%

PainReform Ltd. (PRFX) shares are progressing more than 5 percent on Monday morning trade. There have been no corporate announcements today. The stock have been on an uptrend since June 30.

Painreform-ltd

PainReform : Form 20-F ☒ Form 40-F ☐

Form 20-F ☒ Form 40-F ☐ This Report on Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 (Registration No. 333-257968 and 333-265902) a...

Painreform-ltd
Nasdaq-capital-market
Markets

PainReform (PRFX) Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110

PainReform (PRFX) Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Ilan-hadar
Painreform-ltd
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Crescendo-communications-llctel
Exchange-commission
Nasdaq
Wall-street
Drug-master-file
Chief-executive-officer
Regarding-forward-looking-statementsthis
Annual-report

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Ilan-hadar
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Exchange-commission
Crescendo-communications-llctel
Nasdaq
Painreform-ltd
Drug-master-file
Chief-executive-officer
Regarding-forward-looking-statementsthis
Annual-report
Hadarchief-executive-officerpainreform-ltd-tel

PainReform's Phase 3 Trial Of PRF-110 Delayed Due To Supplier Issue

(RTTNews) - Shares of PainReform Ltd. (PRFX), a clinical-stage specialty pharmaceutical company, slipped nearly 14% in after-hours trading on Wedn...

Ilan-hadar
Painreform-ltd
Drug-master-file
Chief-executive-officer

PainReform (PRFX) Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110

PainReform (PRFX) Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Texas
United-states
Ilan-hadar
Crescendo-communications-llctel
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Exchange-commission
Painreform-ltd
Nasdaq
Chief-executive-officer
Generally-recognized
Regarding-forward-looking-statementsthis

PainReform Ltd: PainReform Provides Business Update for the First Quarter of 2023

TEL AVIV, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established

Israel
Texas
United-states
Ilan-hadar
Us-congress-joint-economic-committee
Painreform-ltd
Exchange-commission
Crescendo-communications
Nasdaq
Chief-executive-officer
Joint-economic-committee
First-quarter-ended-march

PainReform Provides Business Update for the First Quarter of 2023

PainReform Provides Business Update for the First Quarter of 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Texas
United-states
Ilan-hadar
Painreform-ltd
Us-congress-joint-economic-committee
Nasdaq
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Crescendo-communications-llctel
Exchange-commission
Chief-executive-officer
Joint-economic-committee

PainReform Ltd. (NASDAQ:PRFX) Short Interest Update

PainReform Ltd. (NASDAQ:PRFX – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 67,400 shares, a growth of 28.4% from the March 15th total of 52,500 shares. Based on an average daily volume of 276,000 shares, the days-to-cover […]

Israel
Painreform-company-profile
Nasdaq
Empirical-financial-services
Painreform-ltd
Exchange-commission
Get-rating
Financial-services
Empirical-wealth-management
Reform-ltd
Painreform-daily

vimarsana © 2020. All Rights Reserved.